Tryptophan, for instance, is well known to be catabolized by the enzyme indoleamine-2,3-dioxygenase (IDO) in the tumor microenvironment, producing kynurenine and other metabolites that suppress immune responses. This evidence concerns the gene IDO2 and neoplasm.